Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trial

Schröder, Dominik; Heinemann, Stephanie; Heesen, Gloria; Klawonn, Frank; Mikuteit, Marie; Niewolik, Jacqueline; Steffens, Sandra; Behrens, Georg; Jablonka, Alexandra; Müller, Frank

doi:10.1186/s40001-022-00727-7

Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trial

ISSN

2047-783X

Date Issued

2022-06-22

Author(s)

Schröder, Dominik

Heinemann, Stephanie

Heesen, Gloria

Klawonn, Frank

Mikuteit, Marie

Niewolik, Jacqueline

Steffens, Sandra

Behrens, Georg

Jablonka, Alexandra

Müller, Frank

DOI

10.1186/s40001-022-00727-7

Abstract

The influence of immunosuppressive therapy on immunogenicity after COVID-19 vaccination remains unclear. This study surveys patients who receive immunosuppressive therapy about whether or not they paused their immunosuppressive medication while receiving SARS-CoV-2 vaccination.